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Abstract
Background: Neurotoxicity and pulmonary dysfunction are well-recognized problems associated with
prolonged human exposure to high concentrations of airborne manganese. Surprisingly, histological
characterization of pulmonary responses induced by manganese remains incomplete. The primary
objective of this study was to characterize histologic changes in the monkey respiratory tract following
manganese inhalation.
Methods: Subchronic (6 hr/day, 5 days/week) inhalation exposure of young male rhesus monkeys to
manganese sulfate was performed. One cohort of monkeys (n = 4–6 animals/exposure concentration) was
exposed to air or manganese sulfate at 0.06, 0.3, or 1.5 mg Mn/m3 for 65 exposure days. Another eight
monkeys were exposed to manganese sulfate at 1.5 mg Mn/m3 for 65 exposure days and held for 45 or 90
days before evaluation. A second cohort (n = 4 monkeys per time point) was exposed to manganese sulfate
at 1.5 mg Mn/m3 and evaluated after 15 or 33 exposure days. Evaluations included measurement of lung
manganese concentrations and evaluation of respiratory histologic changes. Tissue manganese
concentrations were compared for the exposure and control groups by tests for homogeneity of variance,
analysis of variance, followed by Dunnett's multiple comparison. Histopathological findings were evaluated
using a Pearson's Chi-Square test.
Results:  Animals exposed to manganese sulfate at ≥0.3 mg Mn/m3 for 65 days had increased lung
manganese concentrations. Exposure to manganese sulfate at 1.5 mg Mn/m3 for ≥15 exposure days
resulted in increased lung manganese concentrations, mild subacute bronchiolitis, alveolar duct
inflammation, and proliferation of bronchus-associated lymphoid tissue. Bronchiolitis and alveolar duct
inflammatory changes were absent 45 days post-exposure, suggesting that these lesions are reversible
upon cessation of subchronic high-dose manganese exposure.
Conclusion:  High-dose subchronic manganese sulfate inhalation is associated with increased lung
manganese concentrations and small airway inflammatory changes in the absence of observable clinical
signs. Subchronic exposure to manganese sulfate at exposure concentrations (≤0.3 mg Mn/m3) similar to
the current 8-hr occupational threshold limit value established for inhaled manganese was not associated
with pulmonary pathology.
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Background
There is growing evidence to suggest that a wide variety of
respirable particles can induce lung injury under certain
exposure conditions. Clinical recognition of this hazard
originally stemmed from occupational studies examining
workplace exposure to metals, asbestos, silica, coal, and
other biologically active particles [1,2]. However, particu-
late-induced lung injury is not confined to the workplace.
There is strong epidemiologic evidence for significant
associations between respiratory morbidity, including
exacerbations of asthma and mortality, with exposure to
relatively low ambient particulate matter concentrations
[3,4]. This association has contributed to the adoption of
more stringent ambient air quality standards for respira-
ble particulate matter by the United States Environmental
Protection Agency and other health organizations.
Particulate matter is not a single entity but rather a mix-
ture of many subclasses of pollutants including metals,
sulfate, acids, ammonium, nitrate, organic compounds,
and minerals. Depending on emission source, metals may
represent a significant proportion of a particulate matter
sample [5]. Soluble metals have been implicated in partic-
ulate matter-associated cardiopulmonary disease in
healthy and compromised individuals [6-8]. One metal
found in ambient air is manganese. Airborne manganese
sources include wind erosion of dusts and soils, anthropo-
genic fugitive dusts, and emissions from automobiles,
power plants, coke ovens, municipal waste incinerators,
and metal smelting operations [5]. Ambient air manga-
nese concentrations are typically quite low, ranging
between 5 and 33 ng Mn/m3 [9]. Significant occupational
manganese exposure (≥0.2 mg Mn/m3) can occur in some
workers involved in ferroalloy production, iron and steel
foundries, and welding [9].
Workers exposed to high atmospheric manganese concen-
trations frequently demonstrate an increased incidence of
cough and other signs associated with bronchitis [10,11].
Acute inhalation of air with extremely high manganese
concentrations (≥1 mg Mn/m3) can result in pneumonitis
[12]. Although manganese-induced pneumonitis has
been recognized since the mid-1940's, histological charac-
terization of the pulmonary response remains incom-
plete. Most experimental exposures in laboratory animals
have shown only minor lung pathology despite the
administration of high doses of manganese oxides by
intratracheal instillation or inhalation [13-18]. Far less is
known about the potential respiratory effects induced by
exposure to other inorganic forms of manganese. Manga-
nese chloride instillation into rabbits failed to induce sig-
nificant pulmonary pathology [19]. Dorman et al. [20]
showed that subchronic exposure of rats to manganese
sulfate (MnSO4) was associated with rhinitis in the ante-
rior part of the nose. To our knowledge, histologic assess-
ment of pulmonary changes occurring in association with
subchronic inhalation of MnSO4 has not been performed
and is the subject of our study. Herein, we report that
subchronic high-dose inhalation exposure of nonhuman
primates to MnSO4 resulted in mild subacute bronchioli-
tis, alveolar duct inflammation, and proliferation of bron-
chus-associated lymphoid tissue (BALT), in the absence of
rhinitis or other forms of nasal pathology.
Methods
Chemicals
Manganese (II) sulfate monohydrate (MnSO4·H2O) was
obtained from Aldrich Chemical Company, Inc. (Milwau-
kee, WI).
Animals
This study was conducted under federal guidelines for the
care and use of laboratory animals [21] and was approved
by the CIIT Centers for Health Research (CIIT) Institu-
tional Animal Care and Use Committee. Additional end-
points evaluated in this study, but not presented in the
present manuscript, included determination of manga-
nese concentrations in additional tissues and magnetic
resonance imaging (MRI) of the brain. We chose to use
rhesus monkeys since they are extensively used in toxicol-
ogy studies, manganese-exposed monkeys develop distri-
bution patterns for this metal within the brain that mimic
those seen in heavily exposed people [22], and there are
anatomically-based simulation models for air flow in the
macaque upper and lower respiratory tracts [23,24].
Thirty-six male rhesus monkeys purchased from Covance
Research Products, Inc. (Alice, TX) were used in this study.
Monkeys were 17 to 22 months old at the time of their
arrival at CIIT. Animals were screened for the nasal para-
site  Anatrichosoma spp. herpes B, simian immunodefi-
ciency virus, simian respiratory virus, pulmonary
acariasis, and tuberculosis, and were subjected to a thor-
ough clinical examination including an evaluation of pre-
exposure blood samples for routine hematology and clin-
ical chemistry. The results of these evaluations were
within normal limits.
Assignment of animals to treatment cohorts considered
the age of the animal. Assignment occurred so that the
animals were between 20 and 24 months of age at the
start of the inhalation exposure. Randomization of ani-
mals to treatment groups occurred prior to the start of the
inhalation exposure and was based upon a weight rand-
omization procedure. Animals were acclimated to the
facility for at least 43 days prior to the start of the first
inhalation exposure. Additional endpoints evaluated in
this study, but not presented in the present manuscript,
included magnetic resonance imaging (MRI) of the brain,
post-exposure clinical chemistry and hematological
evaluations, and determination of tissue manganeseRespiratory Research 2005, 6:121 http://respiratory-research.com/content/6/1/121
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concentrations in the central nervous system and other
organs.
Animal Husbandry
Animal rooms were maintained at daily temperatures of
22 ± 4°C, relative humidity of 30–70%, and an air flow
rate sufficient to provide 10–15 air changes per hour.
Lighting was controlled by automatic controls (lights on
approximately 0600–1800). All exposures were con-
ducted during the animal's light cycle (approximately
from 0800 to 1400). All animals were housed in animal
rooms or exposure chambers within CIIT's animal facility.
This facility is accredited by the Association for Assess-
ment and Accreditation of Laboratory Animal Care, Inter-
national. A certified primate chow (# 5048) diet from
Purina Mills (St. Louis, MO) was fed twice-a-day (total
daily amount fed was approximately 4% of the animal's
body weight). Dietary supplements were also used as part
of CIIT's nonhuman primate enrichment program. These
supplements included fruits (e.g., oranges, raisins,
apples), vegetables (e.g., carrots), and treats (e.g., honey,
candies, cereal, fruit juices) purchased from a local grocery
store. Reverse osmosis purified water was available ad libi-
tum. During non-exposure periods, domiciliary stainless
steel cages (0.4 m2 × 0.8 m tall) suitable for housing
macaque monkeys (Lab Products, Inc.; Seaford, DE) were
used to individually house monkeys. On each exposure
day, animals were transferred to 0.2 m2 × 0.6 m tall stain-
less steel cages (Lab Products, Inc.; Seaford, DE) that were
designed to fit within the 8-m3 inhalation chambers. Ani-
mals were moved back to their domiciliary cages after the
end of each 6-hr exposure.
Manganese Exposures
MnSO4 aerosol concentrations of 0.18, 0.92, and 4.62 mg
MnSO4/m3, corresponding to 0.06, 0.3, and 1.5 mg Mn/
m3, were generated for this study. Control animals were
exposed to filtered air. Animal exposures were conducted
as described in Figure 1. Four 8-m3 stainless steel and glass
inhalation exposure chambers with glass doors and win-
dows for animal observation were used. Animal position
within the inhalation chambers was rotated weekly to
minimize the impact of any undetected differences in the
environment or in the MnSO4 exposure concentrations.
Air flow through the 8-m3 inhalation chamber was typi-
cally maintained at a rate sufficient to provide at least 12
air changes per hour. Airflow through each chamber was
monitored continuously during each exposure and
recorded every 30 minutes. Temperature and relative
humidity inside each inhalation chamber were recorded
every 30 minutes during each 6-hr exposure. The average
chamber temperature and relative humidity during the 6-
hr exposure period were maintained at 18–26°C and 50 ±
20%, respectively. Methods describing the generation of
the MnSO4  atmosphere with a dry powder generator
(Wright Dust Feeder, Model WDF-II, BGI, Inc., Waltham,
MA) and the characterization of the subsequent aerosol
have been previously described [25]. MnSO4 was packed
in separate dry powder generator cups at pressures
between 2000 and 3000 psi (Model 3912, Carver Inc.,
Wabash, IN) using a hydraulic press (Model C, Carver
Inc., Menomonee Falls, WI).
Necropsy Procedures
Necropsies were performed the day following the last
inhalation exposure (i.e., 12–18 hr after termination of
the final inhalation exposure). Food was withheld over-
night prior to necropsy. Monkeys were anesthetized with
ketamine (20 mg/kg, IM, Fort Dodge Animal Health, Fort
Dodge, IA) and euthanized with pentobarbital (80–150
mg/kg, IV, Henry Schein Inc., Port Washington, NY) fol-
lowed by exsanguination. Following euthanasia, the lungs
and other thoracic organs were removed, weighed, and
inspected for gross lesions. The left primary bronchus was
ligated and the left lung separated for determination of tis-
sue manganese concentration. The right lung and trachea
were then inflated with 10% neutral-buffered formalin
using 30-cm of hydrostatic pressure [26]. The olfactory
epithelium was excised for chemical analysis and the
remaining nasal tissues, including the nasopharynx and
larynx, were stored in 10% neutral-buffered formalin. The
larynx samples were decalcified in 10% formic acid
(Fisher Scientific International, Inc., Hampton, NH) for
two days. Cranial tissues were decalcified in RDO® (Apex
Engineering Products Corporation, Plainfield, IL) for up
to 6 days. Following decalcification, tissues were washed
in running tap water for at least 6 hr. Following fixation
(and decalcification when appropriate), representative
Experimental design overview Figure 1
Experimental design overview. Group size equals 4 
monkeys per exposure group, with the exception of the 0 
and 0.06 mg Mn/m3 exposure groups (n = 6 monkeys/expo-
sure concentration). Lung manganese concentrations and 
respiratory histologic changes were evaluated after 15, 33, or 
65 exposure days or 45 or 90 days after the 65th exposure 
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samples of the lung, trachea, larynx, oropharynx, tracheo-
bronchial lymph nodes, and nose were collected from
each animal. Tissue samples were trimmed, embedded in
paraffin, and five-µm thick sections were cut and stained
with hematoxylin and eosin for light microscopic evalua-
tion. Histologic specimens were examined by an experi-
enced veterinary pathologist (Howroyd).
Tissue manganese concentrations
Tissue samples collected for chemical analyses were stored
in individual plastic containers, frozen in liquid nitrogen,
and stored at approximately -80°C until chemical analy-
ses were performed. Lung and olfactory epithelium man-
ganese concentrations were determined by graphite
furnace atomic absorption spectrometry using previously
published methods [27].
Statistics
Tissue manganese concentrations were compared for the
exposure and control groups by tests for homogeneity of
variance (Levene's test), analysis of variance (ANOVA),
and Dunnett's multiple comparison procedure for
significant ANOVA. Histopathological findings were eval-
uated using a Chi-Square test. Statistical analyses were
performed using SAS Statistical Software. A probability
value of <0.01 was used for Levene's test, while <0.05 was
used as the critical level of significance for all other statis-
tical tests. Unless otherwise noted, data presented are
mean values ± standard error of the mean (SEM).
Results
Test atmospheres
No significant differences in the test aerosol characteristics
were observed between the two exposure cohorts (Table
1). Particles of unknown composition (arising from ani-
mal dander and other background sources) were present
in the control chamber at an overall average concentration
± standard deviation (SD) of 0.004 ± 0.002 mg/m3. The
calculated mass median aerodynamic diameter (MMAD)
for the particles in the control chamber was 3.9 µm.
Lung and olfactory epithelium manganese concentrations 
following MnSO4 exposure
Lung and olfactory epithelium manganese concentrations
are presented in Table 2. Animals exposed to MnSO4 at
≥0.3 mg Mn/m3 for 65 exposure days developed increased
lung manganese concentrations. Animals exposed to
MnSO4 at ≥0.06 mg Mn/m3 for 65 exposure days devel-
oped increased olfactory epithelium manganese concen-
trations. Increased lung and olfactory epithelium
manganese concentrations developed within three weeks
of exposure to MnSO4 at 1.5 mg Mn/m3. Within 45 days
after completion of the 65-day inhalation exposure to
MnSO4 at 1.5 mg Mn/m3 regimen, lung and olfactory epi-
thelium manganese concentrations were not different
from those seen in air-exposed controls.
Respiratory tract pathology following MnSO4 exposure
Manganese exposure did not affect absolute or relative
lung weights and did not result in coughing, dyspnea, or
other respiratory signs (data not shown). High-dose expo-
sure to MnSO4 was associated with an increased incidence
of minimal to mild subacute bronchiolitis (Table 3).
These lesions consisted of infiltrates of lymphocytes,
along with neutrophils and occasional eosinophils, pri-
marily surrounding the terminal and respiratory bronchi-
oles and/or alveolar ducts, but sometimes extending into
the lamina propria (Figure 2). Macrophages with moder-
ate amounts of pale-staining cytoplasm were occasionally
observed in the adjacent airway lumen. Although the
overlying epithelium generally appeared intact, because it
is normally very thin at the level of the distal airways, it is
difficult to confirm that epithelial integrity was unaf-
fected. These changes appeared to be reversible upon
cessation of MnSO4 exposure. An increased incidence of
enhanced proliferation of BALT in association with
Table 1: Characteristics of manganese aerosols generated for whole-body exposures in this study (means ± SD)
Nominal MnSO4 exposure concentration (mg/m3)
0.18 0.92 4.62a 4.62b
Actual exposure concentration (mg MnSO4/m3)c 0.19 ± 0.01 0.97 ± 0.06 4.55 ± 0.33 4.45 ± 0.35
Geometric mean diameter (µm)d 1.04 1.07 1.12 1.04
Geometric standard deviation (σg)d 1.51 1.54 1.58 1.50
Mass median aerodynamic diameter (µm)e 1.73 1.89 2.12 1.72
a Cohort 1
b Cohort 2
c Based on continuous chamber monitoring with a calibrated optical particle sensor (Real-Time Aerosol Sensors, Model RAM-S, MIE, Inc., Billerica, 
MA).
d Based on biweekly aerodynamic particle size spectrometry (Aerodynamic Particle Sizer, Model 3320, TSI, Inc., St. Paul, MN) measurements.
e Calculated value [56]Respiratory Research 2005, 6:121 http://respiratory-research.com/content/6/1/121
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smaller (≤500  µm) airways also occurred in monkeys
exposed to the highest MnSO4 concentration (1.5 mg Mn/
m3) (Figure 3). Some BALT foci included germinal center
formation. The incidence of increased BALT was highest
in monkeys exposed to 1.5 mg Mn/m3for 33 exposure
days (Table 3) suggesting that BALT proliferation may
subside even in the face of ongoing manganese exposure.
Proliferation of BALT occurred in one animal exposed to
MnSO4 at 0.3 mg Mn/m3; however, this increase was only
minimal and was not statistically significant.
Several of the MnSO4-exposed animals had minimal acute
alveolitis. However, this finding was considered unlikely
to be treatment-related since no statistically significant
dose-response relationship was observed. Minimal
changes consistent with chronic bronchiolitis were
Table 2: Olfactory epithelial and lung manganese concentrations in young monkeys following exposure to air or MnSO4. Manganese 
concentrations were determined by graphite furnace atomic absorption spectrometry and are expressed as mean ± SEM µg Mn/g 
tissue wet weight. Young male rhesus monkeys (n = 4 except where noted) were exposed to either air or MnSO4 6 hours/day, 5 days/
week.
Tissue MnSO4 exposure concentration (mg Mn/m3) 15 33 Exposure Day 65 65 [+45]a 65 [+90]a
Olfactory epithelium 0 0.42 ± 0.01b
0.06 1.22 ± 0.15*b
0.3 2.96 ± 0.46*
1.5 6.10 ± 0.39* 7.34 ± 0.70* 7.10 ± 2.01* 0.65 ± 0.04 0.69 ± 0.11
Lung 0 0.15 ± 0.03b
0.06 0.18 ± 0.01b
0.3 0.25 ± 0.02*
1.5 0.39 ± 0.06* 0.35 ± 0.02* 0.33 ± 0.04* 0.09 ± 0.01 0.06 ± 0.01
a Number in brackets indicates number of days post exposure assessment.
b n = 6.
* p < 0.05
Table 3: Incidence of MnSO4-induced microscopic lesions observed in young male rhesus monkeys exposed to MnSO4. Incidence is 
expressed as number affected/number examined.














1.5 2/4† 3/4* 1/4 2/4† 1/4
a Number in brackets indicates number of days post exposure assessment
b Subacute bronchiolitis was observed in one monkey; however, in this animal only, this lesion was observed in conjunction with aspirated food 
particles.
* p < 0.05 (Pearson's chi-square test)
† p = 0.053 (Pearson's chi-square test)Respiratory Research 2005, 6:121 http://respiratory-research.com/content/6/1/121
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observed in several control as well as MnSO4-exposed ani-
mals. As such, these changes were not considered to be
treatment-related. The majority of lung sections
examined, including those taken from controls, had scat-
tered deposits of brown-green pigment in the interstitial
tissue. Such chronic bronchiolitic changes characterized
by lung pigment deposits are commonly seen in monkeys
with lung mites [28,29]. The most common lung mite is
Pneumonyssus simicola and this agent occurs with nearly
100% incidence in rhesus monkeys [28,29]. Animals used
on this study were treated with ivermectin prior to use;
thus it is unlikely that superimposed active mite infection
occurred. This conclusion is further supported by the
absence of microscopic evidence of mites.
Bronchiolitis Figure 2
Bronchiolitis. Moderate subacute bronchiolitis in a monkey exposed to the highest (1.5 mg Mn/m3) MnSO4 exposure concen-
tration for 15 exposure days (right). Normal appearing bronchioles present in an air-exposed control monkey (left). (10×)
BALT proliferation Figure 3
BALT proliferation. Peribronchial BALT proliferation in a monkey exposed to the highest (1.5 mg Mn/m3) MnSO4 exposure 
concentration for 65 exposure days (right). Normal appearing BALT present in an air-exposed control monkey (left). (4×)Respiratory Research 2005, 6:121 http://respiratory-research.com/content/6/1/121
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One animal from each of the 0.06 and 1.5 mg Mn/m3
exposure groups had minimal or mild, basophilic foci in
the nerves of the nose. The spherical basophilic foci were
approximately 40 µm in diameter and consisted of con-
centric lamellae (Figure 4). The foci were Periodic acid-
Schiff stain positive but failed to stain with alizarin red,
von Kossa's, or Perl's stains (for calcium or iron) and were
not birefringent in polarized light (data not shown). Sim-
ilar foci were present in the nasal epithelium of three
other animals, including one control animal. Thus, it is
unlikely that these foci were induced by MnSO4 exposure.
X-ray microanalysis of foci taken from the decalcified
nasal epithelium of a single monkey from the 1.5 mg Mn/
m3 exposure group showed the presence of sulfur but no
other ions (data not shown). Thus, the basophilic foci
noted in the nasal nerves were most likely glycoproteina-
ceous inclusion bodies (i.e., corpora amylacea) or psam-
moma bodies. Similar deposits have been observed in the
olfactory nerves of untreated rhesus monkeys and rats
(Howroyd, unpublished observations), in the olfactory
tracts of humans [30], and in the brains of mice [31] and
monkeys [32,33].
Discussion
Pulmonary inflammation is a common response to the
inhalation of various types of particles including manga-
nese [34]. In the present study, monkeys exposed to the
highest MnSO4 concentration (1.5 mg Mn/m3) developed
subacute bronchiolitis and proliferation of BALT. Bron-
chiolitis included an infiltrate of acute inflammatory cells
(neutrophils) in the peribronchiolar connective tissues in
the centriacinar region. These lesions developed relatively
rapidly as they were observed in monkeys exposed to
MnSO4 for only 15 exposure days. However, with ongoing
MnSO4  exposure, the bronchiolitic lesion progressed,
affecting a larger percentage of respiratory bronchioles
examined. Bronchiolitis resolved rapidly after cessation of
MnSO4 exposure and was absent 45 days after the end of
the 13 week exposure to MnSO4 at 1.5 mg Mn/m3.
Monkeys and human beings share similar lung anatomy
[35], and their respiratory bronchioles and other small
airways have similar sensitivity to inhaled toxicants such
as cigarette smoke, coal dust, and ozone [36-38].
Following bronchiolitis, people are often noted to have
increased wheeze, cough, and asthma, increased airway
responsiveness, and reduced lung function due primarily
to airflow obstruction [39]. In the present study, signs
referable to the respiratory system were not recognized in
the monkeys developing manganese-induced bronchioli-
tis. Although pulmonary function was not assessed in our
study, reduced forced expiratory volume in one second
(FEV1) and forced vital capacity (FVC) have been reported
in workers that have been chronically exposed to high lev-
els of manganese dust [10,40].
Particles deposited in the lung can be retained in the lung
interstitium [41] or cleared via the mucociliary apparatus
or through the lymphatic system [42]. Alternatively, parti-
cles may be transported from the lung via alveolar macro-
phages or neutrophils with subsequent accumulation in
the BALT and tracheobronchial lymph node [42,43].
Thus, as a lymphoepithelial organ, the BALT is critical to
the immune defense of the lung and to alveolar clearance
of particles and lung pathogens. Proliferation of BALT has
been observed in rodents following inhalation exposure
to carbon black and silica [44,45]. There is evidence that
BALT proliferation occurs in humans with panbronchioli-
tis, chronic hypersensitivity pneumonitis, and other
chronic inflammatory airway disease [46,47]. Prolifera-
tive BALT lesions observed in these disease conditions are
comparable to those observed in the MnSO4-exposed
monkeys, suggesting that BALT proliferation in the man-
ganese-exposed monkeys may be related to the local air-
way immune response secondary to inflammation
induced by MnSO4.
Some agents that target the lung may also affect the upper
airways as well. Our laboratory has recently reported that
rats exposed subchronically to MnSO4 (at 0.5 mg Mn/m3)
develop a mild reversible inflammatory change consisting
of pleocellular inflammatory infiltrates and fibrinon-
ecrotic debris within the nasal respiratory epithelium
[20]. These lesions occurred primarily in high airflow
Basophilic foci in nerves Figure 4
Basophilic foci in nerves. Basophilic foci (arrow) in nerves 
of olfactory mucosa from a monkey exposed to MnSO4 at 
0.06 mg Mn/m3, for 65 days (40×).Respiratory Research 2005, 6:121 http://respiratory-research.com/content/6/1/121
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regions and were consistent with mild irritation. In the
present study, however, despite a 15-fold increase in nasal
epithelial manganese concentrations, we did not observe
any chemical-related nasal pathology in monkeys
exposed to MnSO4. Although nasal pathology did not
occur, the fate of the manganese that is initially deposited
in the nose and subsequently absorbed by the olfactory
epithelium remains toxicologically important. Experi-
ments from our laboratory have shown that manganese
deposited on the olfactory epithelium can undergo
transport along the olfactory nerve with subsequent deliv-
ery to the olfactory bulb [48].
Our interest in MnSO4 stems from the use of manganese
in the gasoline fuel additive methylcyclopentadienyl
manganese tricarbonyl (MMT). Automobiles that use
MMT in the fuel and are equipped with catalytic convert-
ers emit manganese primarily in the phosphate and sul-
fate forms with smaller amounts of manganese oxides
also being discharged [49]. The manganese exposure con-
centrations used in this study bracket several human expo-
sure scenarios. Prolonged human exposure to the highest
MnSO4 concentration used in this study (1.5 mg Mn/m3)
can occur among manganese miners and prolonged expo-
sure is associated with frank neurotoxicity and respiratory
disease [9]. Our mid-dose exposure concentration is anal-
ogous to the current 8-hr Threshold Limit Value (TLV) for
inhaled manganese of 0.2 mg Mn/m3 that has been estab-
lished by the American Conference of Governmental
Industrial Hygienists (ACGIH). Our lowest exposure con-
centration (0.06 mg Mn/m3) is > 2,000-fold higher than
typical air manganese concentrations observed in the
ambient air including Canadian cities where MMT is
extensively used in gasoline [9,50]. In the present study,
exposure concentrations associated with increased lung
manganese concentrations and lung pathology were
respectively 1.5-and 7.5-fold higher than the current TLV.
The MnSO4 particle size used in this study had an MMAD
of 1.72 to 2.12 µm. Aerodynamic size is an important fac-
tor that influences particle deposition [51]. Several mod-
els based on airway geometry have been developed to
describe particle deposition patterns in humans,
monkeys, and rats [52,53]. The model of Asgharian and
coworkers (1995) predicts a pulmonary deposition effi-
ciency of an aerosol with a particle size of 1.5 µm of
approximately 35% for humans and rhesus monkeys
while the rat had much lower deposition efficiency (6%)
due to higher nasal uptake [52]. The rate of particle clear-
ance from the alveolar region also differs among species.
Rodents clear particles from the lung more quickly than
either monkeys or humans [54]. Anatomical differences
between rodents and primates also affect particle deposi-
tion, retention, and clearance. Rodents lack respiratory
bronchioles and have simple acini. Macaque monkeys
and humans have larger alveoli and alveolar ducts than
rats [55] and have similar numbers of respiratory bronchi-
ole generations between the terminal bronchiole and the
alveolar duct [35,56]. Our results may be especially
important for human risk assessment owing to the fact
that monkeys and human beings share similar lung anat-
omy (i.e., both species have extensive respiratory bronchi-
oles comprised of bronchiolar epithelium and gas
exchange epithelium) [35].
Conclusion
High-dose subchronic manganese sulfate inhalation is
associated with increased lung manganese concentra-
tions, mild subacute bronchiolitis, alveolar duct inflam-
mation, and proliferation of bronchus-associated
lymphoid tissue. Bronchiolitis and alveolar duct inflam-
matory changes were absent 45 days post-exposure, sug-
gesting that these lesions are reversible upon cessation of
subchronic high-dose manganese exposure. These small
airway changes occurred in the absence of observable clin-
ical signs. Subchronic exposure to manganese sulfate at
exposure concentrations (≤0.3 mg Mn/m3) similar to the
current 8-hr occupational threshold limit value estab-
lished for inhaled manganese was not associated with pul-
monary or nasal pathology.
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